There is a particular kind of suffering that goes unnoticed because it arrives quietly. No sudden episode, no dramatic collapse. Just a gradual retreat from life. The walk that used to take twenty minutes now takes thirty, and then the walk stops happening at all. The stairs get replaced by the lift. The evening outing gets replaced by a chair. Family members chalk it up to age. The person living it often does too.
This quiet withdrawal is one of the most underrecognized patterns in heart valve disease among older adults in India. The heart is struggling. The body is compensating.
It is not always normal. Heart valve disease, particularly aortic stenosis, is a treatable condition that can masquerade as ordinary ageing for months or years before it is caught. When it is caught early, medicine has real answers. When it is caught late, those answers become harder to deliver, and the person has already paid a price in lost independence, avoidable hospitalizations, and diminished quality of life.
Recognising this pattern, and understanding when to act on it, can change the course of an older adult's life.
Why India needs to talk about it now
Think of the heart as a pump with four doors. Those doors are the valves, and their entire job is to make sure blood keeps moving forward with every beat. A healthy valve opens fully and closes cleanly. A diseased valve does neither reliably.
Aortic stenosis is what happens when the aortic valve, the main exit door of the heart, becomes stiff and narrow over time. The heart still tries to push blood through. To do that, it has to work harder. For a while, it compensates. Then it cannot. Symptoms appear, first subtly, then unmistakably. And at that point, the clock is running.
Medicines can address the side effects of a struggling heart such as fluid buildup and blood pressure fluctuations. Medicines cannot widen a narrowed valve. Severe symptomatic aortic stenosis generally requires valve replacement, because only replacement removes the mechanical obstruction the heart is fighting against. (2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease)
India's challenge here is layered. The problem is not access to treatment alone. The deeper problem is the gap between a symptom appearing and a diagnosis being made. Many patients reach cardiology centres after months or years of living with breathlessness that was written off as poor fitness, fatigue that was blamed on stress, and dizziness that was attributed to blood pressure or sugar. By the time the correct diagnosis arrives, the heart has often been under sustained stress for far too long, and the options available have narrowed.
Globally, aortic stenosis affects roughly 2 to 3%of adults over 65, and projects that its prevalence will more than double in many countries by 2050. (Age Differences in Aortic Stenosis, IMR Press, 2025)
India’s blind spot in heart valve disease
The detection gap in India is not primarily a technology problem. Echocardiography machines exist in most district hospitals and large clinics. The problem is earlier in the chain, in the moment when a symptom first appears and a clinician or family member decides what to do with it.
Early symptoms of aortic stenosis are clinically ambiguous. Breathlessness could point to anaemia, lung disease, deconditioning, obesity, or the heat. Fatigue could reflect poor sleep or thyroid issues. Chest heaviness gets dismissed as acidity. Dizziness gets managed as a blood pressure problem. These attributions are not always wrong. The trouble is that they can be right and valve disease can still be present at the same time, running quietly in the background, progressing.
A stethoscope examination can offer an early signal. A murmur, an abnormal sound produced by turbulent blood flow through a diseased valve, should prompt further investigation. An echocardiogram then confirms whether a valve problem exists, how significant it is, and how the heart is coping. That sequence, murmur heard, echo ordered, is where detection either happens or does not.
India's pattern of valve disease adds another layer of complexity. Degenerative aortic stenosis, the kind caused by calcium buildup on the valve over decades, is the dominant concern in older adults. An Indian Heart Journal study based on 60,560 echocardiograms over three years reported 3,728 newly diagnosed cases of valvular heart disease, and it also described how aortic stenosis patterns in India include both degenerative and other etiologies. (Etiology and distribution of isolated aortic stenosis in Indian patients – A study from a large tertiary care hospital in north India)
Rheumatic heart disease, which tends to affect younger patients and stems from untreated streptococcal infections, continues to be present in certain populations. This mixed aetiology means that cardiologists and general practitioners need to maintain a wide index of suspicion across different age groups and symptom profiles, not just the textbook presentation. (Etiology and distribution of isolated aortic stenosis in Indian patients, Indian Heart Journal 2020)
Then come the practical barriers that compound the clinical ones. A visit to a cardiology centre can mean an entire day of travel and lost wages for a working family. Older adults in India often minimise their symptoms to avoid troubling children or grandchildren. Follow-up visits get postponed. Echocardiograms recommended three months ago get done six months later, if at all. Each delay is a window in which the valve continues to narrow, and the heart continues to pay the price.
The result is a population of older adults living at a fraction of their functional capacity, not because treatment is unavailable, but because the problem was never properly named.
Why early diagnosis matters after 60
Early diagnosis does not always lead immediately to a procedure. What it does is open a window, for planning, for timing, for choice.
A confirmed diagnosis gives the treating cardiologist the ability to time intervention before the heart weakens irreversibly. Severe aortic stenosis, once symptomatic, tends to decline faster than many patients and families expect. The 2020 ACC/AHA guidelines are unambiguous on this: severe symptomatic aortic stenosis generally requires valve replacement. Medicines can manage the downstream effects of a struggling heart, but they cannot address the valve itself. (2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease)
Early diagnosis also reduces emergency admissions, which are both medically and emotionally costly. A planned discussion about valve replacement in a cardiology outpatient setting is a very different experience from an emergency room conversation after a collapse. The clinical options are broader. The patient and family are calmer. The decisions made are better.
A practical way to judge whether a valve evaluation is overdue is to compare this month with the same month last year. Has the person's stamina dropped noticeably? Are stairs a problem that they were not six months ago? Has breathlessness become part of routine walks? Are there episodes of dizziness, chest heaviness, or near-fainting? Has the person's walking distance quietly shortened?
These are not inevitable features of ageing. These are symptoms that deserve an echocardiogram. That test takes less than an hour and can answer, definitively, whether the heart and its valves are functioning as they should.
Today’s valve treatment choices and what they mean for recovery
Once severe aortic stenosis is confirmed, two main pathways exist for treatment.
Surgical aortic valve replacement, known as SAVR, is open-heart surgery. Decades of evidence support it, and it remains an excellent option for many patients. Transcatheter aortic valve replacement, known as TAVR, places a new valve through a thin tube inserted most often through a blood vessel in the leg, reaching the heart without opening the chest. Over the past decade, TAVR has moved from being an option reserved for the highest-risk surgical patients to an established treatment for a broader range of appropriately selected candidates.
For older adults, TAVR is often appealing because of how much gentler the recovery can feel. Many patients experience a more manageable period after the procedure and return to daily routines sooner than they would following open surgery. Shorter hospital stays reduce the burden on family caregivers. Earlier mobilisation reduces the deconditioning and anxiety that follow prolonged bed rest. A gentler recovery helps older adults rebuild confidence, which matters enormously in people who have spent months quietly losing it.
It is important to say clearly that TAVR is not suitable for every patient. A multidisciplinary heart team evaluates each case based on anatomy, valve characteristics, vascular access, and the overall clinical picture. The best outcome comes from matching the right patient to the right procedure, not from applying one approach to all.
A lifetime view of valve care, durability, monitoring, and next steps
Modern valve care looks well beyond the procedure itself. Planning for what comes next is as important as getting the valve replacement right.
TAVR planning today uses detailed CT imaging to select valve size and positioning precisely. The goal is to reduce leakage around the valve, lower the risk of rhythm disturbances that lead to pacemaker implantation, and protect blood flow to the coronary arteries. Teams also plan with the future in mind. Some patients may need another procedure years later. A lifetime management approach considers options such as valve-in-valve procedures, including TAVR within a previous TAVR in selected cases, so that the first decision does not close off future possibilities.
Durability is the question every patient eventually asks. The honest answer is that it depends on valve type, individual patient factors, and long-term monitoring. Long-term clinical data are therefore essential to modern aortic stenosis care, and published outcomes for specific tissue platforms are an important reference. The seven-year clinical summary from the COMMENCE trial is one such source that offers clinicians data on mid-term surgical tissue valve performance. (Beaver T, Bavaria J, Griffith B, et al. Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis. AATS Annual Meeting, May 2023)
Longer-term outcomes also depend on consistent monitoring after replacement, including watching for changes in valve function, clot-related restriction, rhythm issues, and infection risk. The reassuring reality for patients is that a strong long-term plan has a simple shape: regular follow-up visits and early reporting of any new symptoms.
Protecting the valve after treatment: What patients and families can do
Patients often ask how to take care of a replaced valve. The answer is reassuringly straightforward: a consistent routine that protects the valve and keeps the heart as healthy as possible.
Regular follow-up echocardiograms help detect early changes in valve performance and track how the heart is recovering. Medicines should be taken exactly as prescribed, whether antiplatelet or anticoagulation therapy, or medications for blood pressure, cholesterol, diabetes, or heart failure symptoms. Good dental hygiene matters more than many patients expect, since any replacement valve can be vulnerable to bloodstream infections that begin in the mouth. Patients should discuss precautions before dental procedures with their cardiologist.
Walking plans and cardiac rehabilitation can gradually restore stamina and confidence. Progress should be steady rather than rushed. And certain warning signs should always prompt an immediate call to the treating team: new breathlessness, chest pressure, dizziness, fainting, unexplained fever, or a sudden drop in energy that cannot be explained.
Families are not bystanders in this process. A caregiver who attends follow-up visits often notices early changes before the patient does. That kind of quiet vigilance can be the difference between catching a problem early and discovering it in an emergency room.
The “new normal after 60”
India is living longer, and that makes one shift urgent. Ageing should bring more wisdom, more family time, and more independence. Ageing should not quietly shrink life because a treatable valve problem went unnamed for too long.
Families can lead this change in a practical way. Watch for changes in walking, breathing, and stamina. Treat repeated breathlessness and dizziness as medical signals. Ask for the echocardiogram that clarifies the cause. Seek centres that can explain the full range of appropriate options, including TAVR when suitable, and ask what long-term follow-up will look like from day one.
The goal is not to turn every symptom into fear. The goal is to prevent delay from becoming danger. Early action keeps choices open. Early action protects recovery. Early action preserves the years people have earned.
References:
- 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
- Indian Heart Journal - Etiology and distribution of isolated aortic stenosis in Indian patients e A study from a large tertiary care hospital in north India Ankit Kumar Sahu, Pramod Sagar, Roopali Khanna, Sudeep Kumar, Satyendra Tewari, Aditya Kapoor, Naveen Garg, Pravin K. Goel
- Assessing the Burden of Rheumatic Heart Disease in India : A Global Burden of Disease Analysis (2001-2021) - Aishwar Dixit, MBBS ∙ Sweta Sahu ∙ Roopeessh Vempati, MD ∙Afrasayab Khan
- Artificial Intelligence Enhanced Comprehensive Assessment of the Aortic Valve Stenosis Continuum in Echocardiography (medRxiv, version 2) - Jiesuck Park, Jiyeon Kim, View ORCID ProfileJaeik Jeon, Yeonyee E. Yoon, Yeonggul Jang, Hyunseok Jeong, Youngtaek Hong, Seung-Ah Lee, Hong-Mi Choi, View ORCID ProfileIn-Chang Hwang, Goo-Yeong Cho, View ORCID ProfileHyuk-Jae Chang
- Clinical Summary: Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis Beaver T, Bavaria J, Griffith B, et al. Presented at the American Association for Thoracic Surgery Annual Meeting, May 2023.
- Age Differences in Aortic Stenosis - Tomoyo Hamana, Teruo Sekimoto, Aloke V Finn, Renu Virmani
Dr S Nagendra Boopathy Professor of Cardiology Senior Interventional Cardiologist Lead – Structural Heart Disease Interventions Sri Ramachandra Medical Centre, Chennai .